Transplantation of Human iPS Cell-derived Dopaminergic Progenitors (CT1-DAP001) for Parkinson's Disease (Phase I/II)

NCT06482268 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
7
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of California, San Diego

Collaborators